|
1
|
Economic evaluation of human papilloma virus vaccination in the European Union: a critical review.
|
Intern Emerg Med
|
2011
|
1.72
|
|
2
|
The burden of moderate to severe psoriasis: an overview.
|
Pharmacoeconomics
|
2012
|
1.18
|
|
3
|
Pharmaceutical policy in Italy: towards a structural change?
|
Health Policy
|
2005
|
1.15
|
|
4
|
Comment on: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers".
|
Appl Health Econ Health Policy
|
2014
|
1.06
|
|
5
|
Should we really worry about "launch delays" of new drugs in OECD countries?
|
Eur J Health Econ
|
2007
|
0.96
|
|
6
|
A critical systematic review of budget impact analyses on drugs in the EU countries.
|
Appl Health Econ Health Policy
|
2014
|
0.92
|
|
7
|
Health status, resource consumption, and costs of dysthymia. A multi-center two-year longitudinal study.
|
J Affect Disord
|
2005
|
0.90
|
|
8
|
Pain in primary care: an Italian survey.
|
Eur J Public Health
|
2005
|
0.89
|
|
9
|
Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?
|
Eur J Health Econ
|
2015
|
0.86
|
|
10
|
A review of the costs of managing childhood epilepsy.
|
Pharmacoeconomics
|
2005
|
0.85
|
|
11
|
Drug sales in four European countries still differ.
|
BMJ
|
2003
|
0.85
|
|
12
|
Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies.
|
Pharmacoeconomics
|
2014
|
0.84
|
|
13
|
Biosimilar versus generic drugs: same but different?
|
Appl Health Econ Health Policy
|
2015
|
0.83
|
|
14
|
The Bayesian model on human papillomavirus vaccination in Italy lacks transparency.
|
Med Care
|
2013
|
0.83
|
|
15
|
Budget impact analysis in economic evaluation: a proposal for a clearer definition.
|
Eur J Health Econ
|
2011
|
0.82
|
|
16
|
Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS).
|
Epilepsia
|
2004
|
0.82
|
|
17
|
Economic analysis of newer antiepileptic drugs.
|
CNS Drugs
|
2008
|
0.81
|
|
18
|
Health technology assessment: for whom the bell tolls?
|
Eur J Health Econ
|
2008
|
0.81
|
|
19
|
HPV vaccination for boys? Talking economic sense.
|
J Sex Med
|
2012
|
0.80
|
|
20
|
Healthcare costs of COPD in Italian referral centres: a prospective study.
|
Respir Med
|
2007
|
0.79
|
|
21
|
Could co-payments on drugs help to make EU health care systems less open to political influence?
|
Eur J Health Econ
|
2013
|
0.77
|
|
22
|
Cost minimisation analysis of 12 or 24 weeks of peginterferon alfa-2b + ribavirin for hepatitis C virus.
|
J Med Econ
|
2008
|
0.76
|
|
23
|
Utilization and costs of antiepileptic drugs in the elderly: still an unsolved issue.
|
Drugs Aging
|
2009
|
0.76
|
|
24
|
HPV vaccine prices in Italy.
|
BMJ
|
2011
|
0.75
|
|
25
|
Utilities and QALYs in health economic evaluations: glossary and introduction.
|
Intern Emerg Med
|
2010
|
0.75
|
|
26
|
Re: The health technology assessment of bivalent HPV vaccine Cervarix® in Italy.
|
Vaccine
|
2011
|
0.75
|
|
27
|
To model or not to model: lessons from two vaccinations.
|
Eur J Health Econ
|
2011
|
0.75
|
|
28
|
A critical review of the full economic evaluations of pharmacological treatments for glaucoma.
|
J Med Econ
|
2008
|
0.75
|
|
29
|
Optional copayments on anti-cancer drugs.
|
BMJ
|
2013
|
0.75
|
|
30
|
Direct medical costs of mycosis fungoides in specialized Italian hospital departments.
|
Haematologica
|
2005
|
0.75
|
|
31
|
Direct medical costs of monitoring and treating patients with Takayasu arteritis in Italy.
|
Eur J Health Econ
|
2004
|
0.75
|
|
32
|
The stoma appliances market in five European countries: a comparative analysis.
|
Appl Health Econ Health Policy
|
2002
|
0.75
|
|
33
|
Health status, resource consumption, and costs of dysthymic patients in Italian primary care.
|
Epidemiol Psichiatr Soc
|
2004
|
0.75
|
|
34
|
[Pharmacoeconomic evaluations on antipsychotics in schizophrenia: a review of the Italian studies].
|
Epidemiol Psichiatr Soc
|
2006
|
0.75
|
|
35
|
Medical costs of glaucoma and ocular hypertension in Italian referral centres: a prospective study.
|
Ophthalmologica
|
2007
|
0.75
|
|
36
|
Vaccination planning and vaccine prices in a decentralizing country - Italy.
|
Expert Rev Pharmacoecon Outcomes Res
|
2014
|
0.75
|
|
37
|
Pharmaceutical policy in Italy: Theory, politics and practice.
|
Eur J Health Econ
|
2006
|
0.75
|